VP
Vito J. Palombella
Chief Scientific Officer

Vito J. Palombella insider trades: Surface Oncology (SURF) stock sales

Chief Scientific Officer, Surface Oncology Last trade Aug 3, 2022 23 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
11
Open-market trades
since 2013
2
Companies
last trade 2022

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Vito reports to the SEC

Open-market buys and sales

11 trades reported on SEC Form 4, newest first

DateStockTypeValue
Aug 3, 2022SURF↓ Sell$8K
Jul 21, 2021SURF↓ Sell$161K
Jun 15, 2015INFI↓ Sell$52K
Dec 15, 2014INFI↓ Sell$77K
Nov 26, 2014INFI↓ Sell$71K
Sep 3, 2014INFI↓ Sell$146K
Jul 1, 2014INFI↓ Sell$11K
Feb 25, 2014INFI↓ Sell$71K
Jan 2, 2014INFI↓ Sell$10K
Sep 27, 2013INFI↓ Sell$82K
Jun 20, 2013INFI↓ Sell$429K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

About Vito J. Palombella's insider trades

Vito J. Palombella is Chief Scientific Officer at Surface Oncology (SURF). Since Jun 20, 2013, Vito has reported no open-market purchases and 11 sales worth $1.1M on SEC Form 4. There have been no open-market trades in the last 12 months.

Their filings also include grants and awards (12 filings), option exercises (7 filings), shares returned to the company (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every SURF insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.